Platelet-Rich Plasma in Chronic Joint Pain: An Autologous Alternative to Steroids
In brief
Platelet-rich plasma provides longer-term pain relief than steroid shots
Recent trials and meta-analyses show that while steroid injections ease osteoarthritis pain better in the first weeks, PRP delivers more durable pain reduction and functional gains over months. Inconsistent preparation methods limit reproducibility, so standardized protocols are needed before PRP can replace steroids in routine practice.
- Journal
- Current pain and headache reports (Q1)
- Published
- 23 July 2026
- Study design
- Narrative review / expert opinion
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Marlou Abril, Bruno Alonso, Jun Beom Ku, Ray Pak, David Rosenblum
- PMID
- 42490022
- DOI
- 10.1007/s11916-026-01524-1
Why clinicians should know about it
- Picked for Rheumatology (top studies of the week, 26 July 2026): Platelet‑rich plasma offers longer‑term relief for osteoarthritis pain
Abstract
PURPOSE OF REVIEW: Chronic joint pain, most caused by osteoarthritis, is one of the leading causes of disability worldwide. When conservative management fails, interventional therapies are introduced, with corticosteroid injections being one of the most utilized. However, its clinical utility is limited by its short-term efficacy and by potential structural adverse effects. Platelet-rich plasma has emerged as a compelling alternative, providing both anti-inflammatory and regenerative properties. This review will evaluate platelet-rich plasma as an autologous alternative to corticosteroid injections for the treatment of chronic joint pain due to osteoarthritis. RECENT FINDINGS: Recent systematic reviews, meta-analyses, randomized controlled trials, and cohort studies largely demonstrate that while corticosteroid injections provide superior short-term relief in osteoarthritis, platelet-rich plasma offers more sustained medium and long-term pain relief and functional improvements. However, variability in preparation methods, including single versus double-spin techniques, leukocyte concentration, and platelet concentration limits consistency across studies, and thereby serving as a major limitation. The current body of research on platelet rich plasma demonstrates promising therapeutic potential in the management of osteoarthritis, with long-term efficacy rivaling that of corticosteroid injections. However, further investigations are needed to establish standardized protocols and better define their clinical applications.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.